Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus.

Mucus is a highly viscoelastic and adhesive substance that protects against infection and injury at nearly all entry points to the body not covered by skin. However, mucus also traps potentially life-saving drugs and nucleic acids delivered via synthetic nanoparticles, including those composed of poly(lactic-co-glycolic acid) (PLGA) and poly(e-caprolactone) (PCL), two FDA-approved polymers commonly used in drug delivery applications.[1] Trapped particles, with diffusivities in mucus several thousand-fold lower than in water, do not efficiently reach the deeper mucus layers that are cleared much more slowly, or the underlying epithelium, and are thus eliminated by mucus clearance mechanisms (on the order of seconds to a few hours depending on anatomical site[2]). For sustained or targeted drug delivery to mucosal surfaces, nanoparticles must quickly penetrate mucus gels, a longstanding challenge in drug delivery.[2c]

[1]  C. Pui Rasburicase: a potent uricolytic agent , 2002, Expert opinion on pharmacotherapy.

[2]  Junghae Suh,et al.  Real-time multiple-particle tracking: applications to drug and gene delivery. , 2005, Advanced drug delivery reviews.

[3]  J. Hanes,et al.  New polymeric carriers for controlled drug delivery following inhalation or injection. , 2002, Biomaterials.

[4]  Justin Hanes,et al.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.

[5]  Jean Claude Chaumeil,et al.  A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics , 2006, Pharmaceutical Research.

[6]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[7]  R. Cone,et al.  Barrier properties of mucus. , 2009, Advanced drug delivery reviews.

[8]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[10]  R. Misra,et al.  Biomaterials , 2008 .

[11]  R. Edlich,et al.  Pluronic F-68: a promising new skin wound cleanser. , 1980, Annals of emergency medicine.

[12]  José Juan Escobar-Chávez,et al.  Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[13]  Samuel K. Lai,et al.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.

[14]  J. Tamada,et al.  The development of polyanhydrides for drug delivery applications. , 1992, Journal of biomaterials science. Polymer edition.

[15]  S. Gelskey,et al.  A placebo-controlled multi-centred evaluation of an anaesthetic gel (Oraqix) for periodontal therapy. , 2003, Journal of clinical periodontology.

[16]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .

[17]  Kinam Park,et al.  Control of encapsulation efficiency and initial burst in polymeric microparticle systems , 2004, Archives of pharmacal research.

[18]  R. Emanuele FLOCOR: a new anti-adhesive, rheologic agent. , 1998, Expert opinion on investigational drugs.

[19]  S. Davis,et al.  The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.

[20]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[21]  Denis Wirtz,et al.  Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.

[22]  David Putnam,et al.  Polymers for gene delivery across length scales , 2006, Nature materials.

[23]  C. F. van der Walle,et al.  Engineering biodegradable polyester particles with specific drug targeting and drug release properties. , 2008, Journal of pharmaceutical sciences.

[24]  A. Thombre,et al.  Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy , 2009, Drug development and industrial pharmacy.

[25]  Allan S. Hoffman,et al.  The origins and evolution of "controlled" drug delivery systems. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Jung Soo Suk,et al.  Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. , 2008, Angewandte Chemie.

[27]  D. Wirtz,et al.  Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport* , 2003, Journal of Biological Chemistry.